Robert H. Dworkin

In December 2013, Robert H. Dworkin, PhD joined Olatec’s Drug Development Team and became a member of the Scientific Advisory Board in April 2016. Dr. Dworkin is contributing leading expertise to the development of OLT1177™ Gel in the design of Olatec’s Clinical Trials Program, specifically with regards to assay sensitivity. Dr. Dworkin currently serves at the University of Rochester School of Medicine and Dentistry as Professor of Anesthesiology, Neurology, and Psychiatry and also as Professor in the Center for Human Experimental Therapeutics. Dr. Dworkin is also the Director of the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership with FDA; a member of the U.S. Centers for Disease Control and Prevention Zoster Working Group; and a Special Government Employee of FDA Center for Drug Evaluation and Research. Dr. Dworkin received the American Pain Society’s Fordyce Clinical Investigator Award in 2005 and Bonica Public Service Award in 2014, the Eastern Pain Association’s Bonica Award in 2011, and the American Academy of Neurology’s Max Award for Neuropathic Pain in 2015. Dr. Dworkin received his doctorate from Harvard University in 1977 and his BA from University of Pennsylvania in 1971.In December 2013, Robert H. Dworkin, PhD joined Olatec’s Drug Development Team and became a member of the Scientific Advisory Board in April 2016. Dr. Dworkin is contributing leading expertise to the development of OLT1177™ Gel in the design of Olatec’s Clinical Trials Program, specifically with regards to assay sensitivity. Dr. Dworkin currently serves at the University of Rochester School of Medicine and Dentistry as Professor of Anesthesiology, Neurology, and Psychiatry and also as Professor in the Center for Human Experimental Therapeutics. Dr. Dworkin is also the Director of the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership with FDA; a member of the U.S. Centers for Disease Control and Prevention Zoster Working Group; and a Special Government Employee of FDA Center for Drug Evaluation and Research. Dr. Dworkin received the American Pain Society’s Fordyce Clinical Investigator Award in 2005 and Bonica Public Service Award in 2014, the Eastern Pain Association’s Bonica Award in 2011, and the American Academy of Neurology’s Max Award for Neuropathic Pain in 2015. Dr. Dworkin received his doctorate from Harvard University in 1977 and his BA from University of Pennsylvania in 1971.